Publication | Open Access

A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial

OncologyPancreatic CancerClinical TrialsPlacebo-controlled TrialPharmacotherapyCancer TreatmentMedicineRadiation OncologyPhase 3Gamma TrialHealth Sciences